间歇性胺和神经调节治疗引起协同抗抑郁药相关作用
1Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland.
Biological psychiatry
|October 19, 2025
概括
在小鼠中,间歇性服用胺和电刺激 (ECS) 显示出协同抗抑郁作用. 这种时间敏感的策略增强了突触可塑性和行为结果,没有认知障碍,为抑郁症治疗提供了有前途的方法.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 精神病学是一个精神病学.
背景情况:
- 电疗法 (ECT) 是一种高效的抗抑郁药,但会引起认知副作用,需要多次治疗.
- 胺可以在几个小时内迅速缓解抑郁症的症状,但持续的效果需要重复剂量.
- 结合ECT和胺在临床环境中显示出混合的结果.
研究的目的:
- 研究电刺激 (ECS) 的协同抗抑郁作用,ECT的临床前模型,和小鼠中的胺.
- 为了确定胺和ECS的剂量和间隔是否影响它们的联合疗效.
- 探索ECS和胺对突触可塑性和认知功能的影响.
主要方法:
- 在成年小鼠中利用行为药理学和ex vivo海马片电生理学.
- 测试了ECS和胺可以产生协同作用的抗抑郁药类效应的假设.
- 服用不同剂量和间隔的ECS和胺.
主要成果:
- 间歇性给予 (24小时间隔) 低效剂量的胺和ECS产生了类似抗抑郁药的协同作用的突触和行为效应.
- 单独的胺诱导了海马突触的元可塑性;间歇性的ECS增强了这种效应.
- 联合间歇性胺和ECS改善了结果,而没有认知障碍,与重复ECS不同.
- 同时服用胺和ECS排除了协同效应.
结论:
- 胺和ECS表现出时间敏感的协同抗抑郁作用.
- 向在谷氨基质突触的转塑性可以增强,加速和延长抗抑郁药的结果.
- 间歇性给药策略可能会减少与胺和ECS联合治疗相关的副作用.
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
806
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
806
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
508
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
508
01:30Electroconvulsive Therapy
864
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
864
01:25Antidepressant Drugs: Overview
1.4K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.4K
01:27Combined Effects of Drugs: Synergism
6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.7K